Actively Recruiting
Brain PERfusion Evaluation by Contrast-Enhanced UltraSound
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-06-19
60
Participants Needed
1
Research Sites
101 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of the study is to assess brain tissue perfusion by contrast-enhanced ultrasound perfusion imaging (PerCEUS) in acute brain injuries. More precisely, it aims : * to evaluate the heterogeneity of brain perfusion and thus diagnose brain tissue hypoperfusion with contrast-enhanced ultrasound. * to correlate contrast-enhanced ultrasound with perfusion measurements by usual multimodal monitoring.
CONDITIONS
Official Title
Brain PERfusion Evaluation by Contrast-Enhanced UltraSound
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Admission to intensive care unit for acute brain injury
- Acute brain injury confirmed by CT and/or MRI
- Requiring contrast ultrasound imaging
- Informed consent given by patient or relative
You will not qualify if you...
- Pregnancy
- Insufficient temporal window for ultrasound
- Contraindications to Sonovue contrast agent such as acute coronary syndromes, severe ischemic heart disease needing revascularization, pulmonary arterial hypertension above 90 mmHg, right-left shunt, ARDS, use of dobutamine, or known allergy to Sonovue
- Patient under State Medical Assistance
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Lariboisière Hospital
Paris, France, 75010
Actively Recruiting
Research Team
R
Romain BARTHELEMY, MD
CONTACT
B
Benjamin Glenn CHOUSTERMAN, MD PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here